Bio Refine

Endovascular Annuloplasty Remodeling System

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo, Israel Founded 2019
LinkedIn
Last updated 2026-06-18
Total raised
$900K
Last: 2025-10
Stage
Seed
Founded
2019
Headcount
1
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Bio Refine has developed an endovascular annuloplasty remodeling system, without an implant, for the repair of mitral and tricuspid heart valves.

The technology will offer treatment to patients who cannot currently be treated due to the high risk of open surgery.

The implantless solution offers multiple advantages. With significantly easier regulation, it uses a standard endovascular approach, and the procedure is safe, implant free, repeatable, and does not prevent ancillary procedures.

Funding history · 2 rounds · $900K total

2025-10
Undisclosed
2023-02

Q&A

What is Bio Refine's primary focus?
Bio Refine is developing an endovascular annuloplasty remodeling system designed for the repair of mitral and tricuspid heart valves without the need for an implant.
How many employees does Bio Refine currently have?
Bio Refine operates with 1-10 employees.
What is the total amount of funding Bio Refine has raised to date?
Bio Refine has raised a total of $900,000 USD.
When was Bio Refine founded?
Bio Refine was founded in July 2019.
Which investor participated in Bio Refine's February 2023 funding round?
Peregrine Ventures participated in Bio Refine's funding round in February 2023.
What is the current stage of Bio Refine's product development?
Bio Refine's product is currently in the R&D stage.
Does Bio Refine hold any patents?
Yes, Bio Refine holds one patent.
What is the most recent funding activity for Bio Refine?
In October 2025, Bio Refine had a funding round with participation from.

Team · 1

Founder · Co-Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

minimally-invasivevalvescardiologysurgery-toolsmedical-devices
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)